OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 147 filers reported holding OCULAR THERAPEUTIX INC in Q1 2024. The put-call ratio across all filers is 2.74 and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $4,368,469 | -24.8% | 638,665 | +0.1% | 0.01% | -23.5% |
| Q1 2024 | $5,808,576 | +2.0% | 638,305 | -50.0% | 0.02% | +88.9% |
| Q4 2023 | $5,692,084 | +183.6% | 1,276,252 | +99.7% | 0.01% | +28.6% |
| Q3 2023 | $2,007,195 | -18.1% | 639,234 | +34.6% | 0.01% | -12.5% |
| Q2 2023 | $2,450,484 | – | 474,900 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SUMMER ROAD LLC | 5,618,861 | $79,675,000 | 100.00% |
| Opaleye Management Inc. | 6,480,000 | $91,886,000 | 15.26% |
| DELTEC ASSET MANAGEMENT LLC | 2,167,313 | $30,732,000 | 4.23% |
| Kamunting Street Capital Management, L.P. | 624,201 | $8,851,000 | 3.58% |
| GREAT POINT PARTNERS LLC | 919,887 | $13,044,000 | 2.74% |
| Endurant Capital Management LP | 570,970 | $8,096,000 | 2.22% |
| Rubric Capital Management LP | 2,156,542 | $30,580,000 | 1.92% |
| Affinity Asset Advisors, LLC | 250,000 | $3,545,000 | 1.27% |
| Altium Capital Management LP | 256,152 | $3,632,000 | 0.84% |
| Ikarian Capital, LLC | 700,000 | $9,928,000 | 0.80% |